Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone in Recent-onset Schizophrenia (MARYLU)
NCT05351736Phase 4Unknown
- Sponsor
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
- Start
- Jan 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lurasidone in schizophrenia, sponsored by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Status: unknown.
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT05351736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05351736.